You are looking at a business with a decent headline story: revenue is growing, the market sounds attractive, management has a plausible plan, and the banker materials are neat. But you are not buying the deck. You are buying the next three to seven years of customer demand, sales execution, pricing discipline, churn risk, channel leverage and competitive pressure. That is where buy-side commercial due diligence earns its keep.
In my experience, the best commercial diligence does not try to produce a beautiful 80-page market study. It answers a smaller set of uncomfortable questions before the investment committee has to make a call: is the market real, is the growth plan underwritten by evidence, is the go-to-market engine repeatable, and what would I actually do in the first 100 days if I owned this asset?
The point is not to prove the deal works. The point is to find the conditions under which it does not.
What buyers actually mean by buy-side commercial due diligence
When sponsors search for buy-side commercial due diligence, they usually mean one of four things. The words are the same, but the job to be done is different.
- Market validation: Is the target selling into a market that is large enough, growing enough and structurally attractive enough to support the investment case?
- Customer and revenue quality: Are customers sticky, referenceable and expanding, or is revenue concentrated, fragile and relationship-dependent?
- GTM diligence: Does the sales and marketing motion work outside the founder network, a few rainmakers or a favourable demand cycle?
- Value creation underwriting: Which commercial levers are practical after close: pricing, packaging, sales productivity, channel strategy, account expansion, customer success, retention or new segments?
Those are different questions from financial diligence. They also differ from technology diligence. Financial diligence tells you what happened. Technology diligence tells you whether the product and platform can support the plan. Commercial diligence tells you whether the market and revenue engine are likely to cooperate.
For a mid-market platform investment, I like to connect all three. If the commercial plan assumes enterprise expansion but the product lacks administration, integrations or compliance depth, the plan is not merely ambitious; it is internally inconsistent. If the plan assumes inbound demand will scale but the website, positioning and paid acquisition economics are weak, the growth curve needs pressure-testing. Commercial diligence should not sit in a silo.
The core questions I want answered
I would rather have clear answers to 12 hard questions than a massive report full of generic market language. For most buy-side processes, I work through the following areas.
Market and category reality
Start with the market definition. A common mistake is accepting a broad TAM that the company cannot realistically reach. A vertical SaaS company may claim exposure to a multi-billion-pound market, but its current product, price point, sales motion and compliance posture may only address a narrow slice.
I want to know: who actually buys this, what budget does it come from, what problem is painful enough to fund, and what happens if the customer does nothing? The status quo is often the strongest competitor. In services and software-enabled businesses, I also look for category maturity. Is the market actively pulling solutions in, or does every deal require education, custom scoping and heavy founder involvement?
Customer evidence
Customer calls are valuable, but only if you listen for the right signals. Happy customers will often praise the team and still reveal limitations in product depth, procurement friction, workflow adoption or switching risk.
I pay attention to renewal logic, not just satisfaction. Why do customers renew? Is it because the product is mission-critical, because switching is painful, because the vendor is inexpensive, or because nobody has reviewed alternatives yet? Those are not equal forms of retention.
Revenue concentration and expansion
Revenue concentration is not automatically fatal. A specialist business may have a few large, rational customers and still be a strong asset. The question is whether the concentration is understood and priced into the plan.
I look at top customer dependency, contract terms, renewal dates, pricing history, usage growth, account expansion patterns and the relationship map. If the CEO personally owns the largest accounts and there is no second-line commercial coverage, that is an operating risk. If expansion comes from one-off professional services rather than repeatable product or packaging, that changes the multiple of confidence.
Sales and marketing productivity
Commercial diligence should test the sales engine in plain English. Where do leads come from? Which channels produce qualified opportunities? How long is the sales cycle? Who can sell the product? What does onboarding require? Which objections kill deals?
I do not need a perfect RevOps system to get signal. I do need the numbers to reconcile. If management says sales cycles are 60 days but the CRM shows opportunities ageing for two quarters, there is a conversation to have. If the plan depends on hiring five account executives in the first year, I want to see evidence that the company can recruit, ramp, manage and support them.
Pricing power
Pricing is one of the most under-tested areas in buy-side commercial due diligence. Many companies have never run disciplined pricing work. They inherited a rate card, discounted under pressure, or priced based on founder instinct.
The diligence question is not simply whether prices can go up. It is where pricing power exists without damaging retention or elongating sales cycles. That might mean packaging changes, minimum commitments, value metrics, discount governance, services attach, premium support or annual uplift discipline. In a 100-day plan, pricing work is often practical, but only when supported by customer segmentation and evidence.
A decision framework for the buyer
When I advise a sponsor or CEO, I try to turn commercial findings into a decision rather than a pile of observations. A useful framework has four layers.
Layer 1: Is the investment thesis commercially coherent?
Write the thesis in one paragraph. Then underline every commercial assumption inside it. Examples: the market is underpenetrated; the company can move upmarket; sales capacity can double; churn will remain stable; pricing can increase; a new channel will open; cross-sell will accelerate.
Each assumption needs a confidence rating: proven, plausible, unproven or contradicted. This is a simple exercise, but it exposes where the deal rests on belief rather than evidence.
Layer 2: Which risks change the bid?
Not every issue matters equally. A messy CRM is fixable. A misunderstood buyer persona is more serious. Weak messaging can be repaired. Structural lack of differentiation is harder. A thin pipeline may affect the first year of ownership. A declining category can affect the exit.
I split findings into three buckets: valuation issues, first-100-day operating issues and watchlist issues. Valuation issues should influence price, structure or whether to proceed. Operating issues should become named workstreams. Watchlist issues deserve monitoring but should not derail the deal.
Layer 3: What has to be true in the first 180 days?
If the growth plan requires new sales leadership, repositioning, product packaging and partner development, the buyer needs to decide what can realistically happen first. Management teams have limited bandwidth. A plan with eight commercial initiatives often means none are executed well.
I prefer a sequenced plan: stabilise the base, improve conversion, tighten pricing, then expand segments or channels. The order matters. You do not scale a leaky funnel because the spreadsheet needs growth.
Layer 4: Who will own the work?
Commercial diligence should name owners. If the CEO owns enterprise sales, customer success, partner strategy and product direction, the plan has a dependency problem. If the CRO role is vacant, or the current sales leader is a strong player-coach but not a scaler, the investment case may need an interim operating plan.
This is where I often sit alongside the sponsor and management team after close: not as a delivery vendor, but as a fractional operating partner or technology advisor who keeps the commercial, product and execution threads aligned.
A short comparison of diligence options
There are several ways to run buy-side commercial due diligence. The right option depends on the deal stage, timeline, cheque size and uncertainty.
- Large strategy consultancy: Strong when the sponsor needs broad market mapping, survey capability, many interviews and a formal committee-ready report. The tradeoff is cost, process weight and sometimes a distance from the operating realities after close.
- Specialist commercial diligence boutique: Often efficient for defined sectors or recurring deal types. Good boutiques bring pattern recognition and structured voice-of-customer work. The risk is that the output can still become a report rather than an executable plan.
- Independent operating advisor: Useful when the buyer needs senior judgement, fast synthesis and a bridge into the 100-day plan. This is how I typically work: retained advisory, pre-LOI second opinion, diligence sprint or fractional operating partner support.
- Internal deal team only: Fast and cheap, and sometimes sufficient for add-ons in a familiar market. The risk is confirmation bias, especially when the team already likes the asset or has limited commercial operating depth in the category.
I am not dogmatic about the model. For a contested auction, a sponsor may need a formal diligence provider. For a proprietary process, an experienced advisor can often provide enough signal quickly. For a complex software or tech-enabled services asset, I like pairing commercial work with product and technology review, because the growth story often depends on delivery capacity, architecture, integrations or data quality.
What good buy-side commercial due diligence should produce
A useful output should be decision-grade. I want to see:
- A clear investment thesis test: what is supported, what is weak and what is unknowable before close.
- Market definition with constraints: not just TAM, but realistic reachable segments.
- Customer evidence: renewal drivers, switching risk, buying criteria and expansion potential.
- Competitive positioning: how the company wins, where it loses and whether differentiation is durable.
- GTM assessment: lead sources, sales process, conversion quality, sales capacity, marketing contribution and channel maturity.
- Pricing and packaging view: where margin and revenue uplift may exist, and where increases would create risk.
- Value creation roadmap: the first three to five commercial priorities, sequenced by impact and feasibility.
The absence of precision is not failure. Diligence happens under time pressure with incomplete information. The job is to reduce uncertainty enough to make a better decision and avoid preventable surprises.
When buy-side commercial due diligence is the wrong tool
Commercial diligence is powerful, but it is not always the right first move.
It is the wrong tool when the core question is technical feasibility. If the main risk is whether the platform can scale, whether the codebase is maintainable, whether cybersecurity exposure is material, or whether the product roadmap is credible, start with technology diligence. Commercial work can then test whether the market rewards the technical plan.
It is also the wrong tool when the deal thesis is primarily cost takeout. If the buyer is acquiring a stable business for operational consolidation, procurement leverage or back-office efficiency, commercial diligence may still help, but it should not dominate the workplan.
Another warning sign is timing. If there are only 48 hours to make a bid decision, full commercial diligence is unrealistic. In that situation I would run a focused pre-LOI review: thesis, market sanity check, obvious GTM risks, customer concentration, competitive red flags and first-pass value creation levers. The output should be a go, no-go or bid-with-conditions view.
Finally, commercial diligence is not a substitute for management judgement. A report cannot run pricing, hire sales leadership or rebuild positioning. If the sponsor already knows the asset well, the better spend may be on a short written brief or fractional advisory support aimed at the post-close plan.
Common red flags I look for
Across mid-market technology, services and software-enabled companies, the same patterns recur.
- Growth without attribution: revenue increased, but nobody can explain which channels, segments or motions drove it.
- Founder-led sales dependency: large deals close only when the founder or CEO is deeply involved.
- Weak segment discipline: the company sells to anyone, making product, marketing and customer success harder to scale.
- Discounting hidden as flexibility: price exceptions are treated as customer-centric behaviour rather than margin leakage.
- Pipeline inflation: CRM value looks good, but stage definitions, close dates and qualification are poor.
- Customer success as support: the business says it has account management, but the function is reactive ticket handling.
- Channel optimism: partnerships are in the plan, but there is no evidence of partner-sourced revenue or enablement.
None of these automatically kills a deal. They do, however, affect the value creation plan and the level of operating involvement required after close.
How I would approach this
If you are early in a process, I would start with the narrowest useful question: what would make this deal commercially unattractive, and can we test it quickly? That may be a pre-LOI review rather than a full diligence workstream. If the deal is live and the sponsor needs a fast second opinion, I would use a focused written brief to pressure-test the thesis, GTM motion, customer evidence and first 100-day priorities.
For a more complete process, I would structure buy-side commercial due diligence around five workstreams: market and category definition, customer and revenue quality, GTM engine, pricing power, and post-close value creation. I would then connect those findings to product and technology constraints where they matter. If execution support is required after a plan is agreed, DevriX can provide capacity, but the advisory relationship comes first: I stay close to the sponsor and management team as the senior operating voice.
If you want a concise outside view before committing to a larger process, start with a Written Brief. If you need ongoing support across diligence, the 100-day plan and board-level operating decisions, a Fractional Retainer is usually the cleaner fit.
Good diligence should sharpen the investment decision. Great diligence should also make the first months of ownership less chaotic. That is the standard I would hold buy-side commercial due diligence to.